Offer - Urjas Oil for just ₹ 1 X
Rozuxia F 5 Tablet is a prescription drug, available for use as Tablet. The alternative uses of Rozuxia F 5 Tablet have also been explained below.
The right dosage of Rozuxia F 5 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The side effects typically associated with Rozuxia F 5 Tablet include Nausea or vomiting, Headache, Constipation. While these are the most often observed Rozuxia F 5 Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Rozuxia F 5 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Rozuxia F 5 Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Rozuxia F 5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Rozuxia F 5 Tablet since this can cause severe adverse effects.
Additionally, Rozuxia F 5 Tablet may also adversely react with other medicines. See below for a complete list.
You should also be aware that Rozuxia F 5 Tablet is not safe while driving, and is not addiction.
Rozuxia F 5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rozuxia F 5 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Rozuxia F. It is best to stop taking Rozuxia F immediately and inform your doctor if you notice any discomfort.
Is the use of Rozuxia F 5 Tablet safe during breastfeeding?
Rozuxia F can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Rozuxia F 5 Tablet on the Kidneys?
Rozuxia F has very mild side effects on the kidneys.
What is the effect of Rozuxia F 5 Tablet on the Liver?
Rozuxia F is rarely harmful for the liver.
What is the effect of Rozuxia F 5 Tablet on the Heart?
You may experience side effects on your heart after taking Rozuxia F. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Rozuxia F 5 Tablet unless your doctor advises you to do so -
Is this Rozuxia F 5 Tablet habit forming or addictive?
Forming a habit of Rozuxia F 5 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Rozuxia F 5 Tablet can make you feel drowsy.
Is it safe?
Yes, but take Rozuxia F 5 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Rozuxia F 5 Tablet is not used to treat mental disorders.
Interaction between Food and Rozuxia F 5 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Rozuxia F 5 Tablet together with food.
Interaction between Alcohol and Rozuxia F 5 Tablet
It is difficult to say anything about the effect of Rozuxia F 5 Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650